Bristol Myers reported $7.1B in net income in fiscal year 2025. This represents an increase of 178.8% from the prior fiscal year. Over the trailing 12 months, Q2 FY2025 through Q1 FY2026, the same line adds up to $7.3B in net income. The table below carries 15 fiscal years, from 2011 to 2025, and the quarters Bristol Myers has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
BMYMP Net Income by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
TTM is the trailing twelve months, Q2 FY2025 through Q1 FY2026, summed from the four most recent quarterly filings.
BMYMP Net Income by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
What net income means
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.
More Bristol Myers financials
Frequently Asked Questions
What was Bristol Myers's net income in fiscal year 2025?
Bristol Myers reported $7.1B in net income in fiscal year 2025.
How fast is Bristol Myers's net income growing?
Bristol Myers (BMYMP) net income rose by 178.8% year over year, from -$8.9B to $7.1B in fiscal year 2025.
What is Bristol Myers's net income over the last twelve months?
Bristol Myers (BMYMP) reported $7.3B in net income over the trailing 12 months, Q2 FY2025 through Q1 FY2026, summed from the four most recent quarterly filings.
How has Bristol Myers's net income changed over the years?
Across the 15 fiscal years this page covers, Bristol Myers (BMYMP) net income went from $3.7B in fiscal year 2011 to $7.1B in fiscal year 2025.
What was Bristol Myers's net income in the most recent quarter?
Bristol Myers (BMYMP) reported $2.7B in net income in Q1 2026. This represents an increase of 9.0% from the same quarter a year earlier.
What does net income mean on a financial statement?
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what Bristol Myers (BMYMP) reported on that line in every period on record.